Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 10,564

Document Document Title
WO/2018/187148A1
The present invention relates to a process of making a compound of formula (I). Wherein, R is as defined herein.  
WO/2018/181847A1
The purpose of the present invention is to provide a novel aromatic compound capable of having GPR40 agonistic activity and activity in accelerating GLP-1 secretion. A compound represented by formula (I) (wherein the symbols are as defin...  
WO/2018/176150A1
Novel methods for isolating fish roe/egg extracts, notably a coagulum and a sediment extract, enriched in phospholipids and omega-3 fatty acids are described. Novel compositions comprising omega-3 polyunsaturated fatty acids and micronut...  
WO/2018/181907A1
Provided are a novel carbonyl group-containing sulfonic acid and carboxylic acid, and salts thereof. The present invention is a compound represented by the formula: R1-C(=O)-(CR2 2)n-(OR3)p-(CR4 2)q-L-A (In the formula, R1 is an optional...  
WO/2018/172062A1
A process for preparing an anticorrosion component for antifreeze by oxidation of an oxydiol (I) in which x is 0 (zero) or a positive integer from 1 to 10 with molecular oxygen at a temperature of 20 to 100°C and a partial oxygen pressu...  
WO/2018/175288A1
Provided are compounds, pharmaceutical compositions, cosmetic and dermatological compositions or nutritional supplement compositions, comprising omega-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFAs) and/or their endogenous ...  
WO/2018/164193A1
Provided is a catalyst characterized in that: a metal component containing a first component, which is rhenium, and one or more types of second components selected from a group consisting of silicon, gallium, germanium and indium is supp...  
WO/2018/161175A1
Methods and compositions for inhibiting or preventing neurodegeneration, specifically hippocampal, cortical, and/or retinal ganglion cell neurons (RGC), and degeneration and/or cell loss or treating related disorders and diseases compris...  
WO/2018/157225A1
Methods are provided for synthesis of abscisic acid and 8' analogues thereof (including an enantiopure 8'-acetylene analogue) including methods wherein the previously reported first step of oxidation of 2,6-dimethylphenol (VI) to 2,6- di...  
WO/2018/159560A1
The purpose of the present invention is to provide: a radiation-sensitive resin composition which has excellent LWR performance, resolution, rectangularity of a cross-sectional shape, depth of focus and film shrinkage suppressing propert...  
WO/2018/154314A1
A method of processing an aqueous hemicellulosic stream containing lignin, comprising: (a) contacting an aqueous hemicellulosic stream containing lignin with a C3-8 alkyl alcohol at elevated temperature and acidic pH; (b) separating the ...  
WO/2018/145553A1
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I), compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatricdisorder (e....  
WO/2018/144717A1
The present invention is directed to novel pleuroniutilin antibiotic compounds, intermediates which are useful for making these novel amibioiic compounds aad related methods and pharmaceutical compositions for treating pathogens, especia...  
WO/2018/138369A1
The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3,R4, R5, R6, R7 and X ha...  
WO/2018/133705A1
The present invention relates to crystal forms of GFT-505 and a preparation method and use thereof. The provided crystal forms of GFT-505, CS1, CS2, CS5, and CS6, have high purities, good stabilities, low hygroscopicities, good solubilit...  
WO/2018/134800A1
The object of the invention are dialkyl complexes of gallium and indium having general formula I: and their use for preparing polylactide-pharmaceutically active compound conjugates and for immortal ring-opening polymerisation of heteroc...  
WO/2018/134278A1
The present invention refers to a new process for the synthesis of (9β,10α)-pregn-4-ene-3,20-dione, commonly known as retroprogesterone, having the formula (1) shown below.  
WO/2018/130865A1
A composition for treating headaches and migraines and methods of using same for preventative use to decrease the frequency, duration and severity of headaches and migraines in children and adults.  
WO/2018/119343A1
The present disclosure relates to the production of 8-methyl nonanoic acid and medium chain branched fatty acids, e.g., via microbial fermentation.  
WO/2018/116991A1
The present invention provides a method for decomposing a polyoxalate, which hydrolyzes a polyoxalate in water, and which is characterized by promoting the hydrolysis of the polyoxalate by having a chelating agent for trapping Ca ions or...  
WO/2018/112778A1
The present invention is directed to a process for synthesizing at least one levulinate ester, said process comprising a step of introducing furfuryl ether into a reaction medium and a step of conversion of furfuryl ether into levulinate...  
WO/2018/102399A1
The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders.  
WO/2018/102358A1
The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.  
WO/2018/094753A1
Disclosed is a method for preparing magnesium citrate, comprising the following steps: raw material preparation – preparation of an aqueous citric acid solution – neutralization reaction – material concentration – centrifugal deh...  
WO/2018/095973A1
A method and a system for producing glycolic acid and/or glycolate from sustainable resources.  
WO/2018/094754A1
Disclosed is a method for preparing selenium citrate, comprising the following steps: raw material preparation – preparation of an aqueous citric acid solution – neutralization reaction – material concentration – centrifugal dehy...  
WO/2018/094755A1
Disclosed is a method for preparing copper citrate, comprising the following steps: raw material preparation – preparation of an aqueous citric acid solution – neutralization reaction – material concentration – centrifugal dehydr...  
WO/2018/094757A1
Disclosed is a method for preparing anhydrous trisodium citrate, comprising the following steps: raw material preparation – preparation of a sodium hydroxide solution – neutralization reaction – material concentration – crystal p...  
WO/2018/091551A1
The present disclosure provides biostable cannabinoid compounds according to Formula I, and methods for synthesizing and enhancing the biological concentrations of the compounds, where R1, R2, and R3 are defined as set forth in the discl...  
WO/2018/090929A1
Provided is a method for biologically preparing (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine D-mandelate (I), comprising: (a) performing an asymmetric reduction reaction with a compound of formula (VI) as a substrate in the presence of...  
WO/2018/090717A1
Provided are an ATG analogue, a preparation method therefor and a use thereof, the specific structure of the ATG analogue is as shown in the following three general formulae: formula (I), formula (II), and formula (III) wherein X/Y/Z can...  
WO/2018/093135A3
The present invention relates to a method for preparing 2-hydroxy-gamma-butyrolactone through a biosynthesis pathway and, more specifically, to a method for preparing 2-hydroxy-gamma-butyrolactone from 3-hydroxypropionic acid and formic ...  
WO/2018/093135A2
The present invention relates to a method for preparing 2-hydroxy-gamma-butyrolactone through a biosynthesis pathway and, more specifically, to a method for preparing 2-hydroxy-gamma-butyrolactone from 3-hydroxypropionic acid and formic ...  
WO/2018/087753A1
The present invention provides cationic lipids and lipid nanoparticle formulations comprising these lipids, alone or in combination with other lipids. These lipid nanoparticles may be formulated with nucleic acids to facilitate their int...  
WO/2018/085618A1
Methods for making acrylic acid, acrylic acid derivatives, or mixtures thereof by contacting a stream containing hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof with either an active catalyst containing an a...  
WO/2018/078363A1
The invention relates to an improved process for the synthesis of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-c]pyridine-5(4H)-carb oxylate, and pharmaceutically acceptable salts thereof, such as the methanesulpho...  
WO/2018/062449A1
Provided are a novel carboxylate salt or sulfonate salt having a plurality of carbonyl groups, and a surfactant. The compound is characterized by being represented by the formula R1–C(=O)–R2–C(=O)–R3–A (in the formula, R1 is a ...  
WO/2018/060354A1
The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them, wherein meanings of the substituents are indicated in the description. Such compounds for use in the treatment of cancer and ot...  
WO/2018/049836A1
A polymorph III of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[4-(2-methy lpropoxy)phenylmethyl]urea tartrate, a preparation method therefor, and a medicinal use. Compared to the existing crystalline forms, the new crystalline form...  
WO/2018/051115A1
A process for the production of glycolic acid or a derivative thereof comprises: reacting formaldehyde with carbon monoxide and water in a carbonylation reactor in the presence of a sulfurcatalyst, said reactor operating under suitable c...  
WO/2018/049216A1
Monomeric bimetal hydroxycitric acid (HCA) compounds are provided. The subject compounds include a divalent metal (X) bonded to the carboxylic acids of C2 and C3 and a monovalent metal (Y) bonded to the carboxylic acid of C1. Also provid...  
WO/2018/049383A1
Disclosed herein are compositions and methods for treating nervous system injury in a subject.  
WO/2018/042265A1
An inkjet ink composition comprising: one or more UV curable monomers; oligomers having one or more acrylic groups; one or more photoinitiators; one or more surfactants; and paraffin wax.  
WO/2018/039390A1
Disclosed are compounds having a monoterpenoid and/or phenylpropanoid moiety and methods of their making and use as pesticidal compounds, such as herbicides.  
WO/2018/025892A1
The purpose of the present invention is to provide a novel polymerizable triptycene derivative compound, which has a structure in which three benzene rings arranged around barrelene having a triptycene skeleton are capable of balanced ro...  
WO/2018/019549A1
The invention discloses 2-((2R,4R)-4-(4-(benzyloxy)-4-methylpent-2-yn-1-yl)-2-(tert- butyl)-5-oxo-1,3-dioxolan-4-yl)acetic acid of formula (XIX), a process for its preparation and processes for its conversion into enantiomerically pure (...  
WO/2018/018151A1
The description relates to, inter alia, recombinant microorganisms, engineered metabolic pathways, chemical catalysts, and products produced through the use of the described methods and materials. The products produced include methylenem...  
WO/2018/012847A1
The present invention provides an integrated system comprising: an electrocatalysis device for producing hydrogen by carrying out an oxidation reaction at an anode and a reduction reaction at a cathode through an electrocatalysis of glyc...  
WO/2018/011741A1
Disclosed are methods for preparing a levulinic acid mixture in a reaction vessel that is, for example, suitable for use in synthesizing a glyceryl ketal of levulinic acid or an ester of levulinic acid comprising distilling a combination...  
WO/2018/010932A1
The present invention relates to a method of reacting starting materials with an activating group, namely alkanes carrying a leaving group and/or olefins, with carbon dioxide under transition metal catalysis to give carboxyl group-contai...  

Matches 1 - 50 out of 10,564